Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin effects on trust and aggression in healthy male volunteers
NL-OMON37316Phase 2Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, double-blind trial of oxytocin (2 arms), sponsored by Erasmus MC. Primary endpoints: Aggression behavior on PSAP, Trust behavior on Trust Game and 2 more. Started Aug 2012; status: active, not recruiting.
02
Drugs
oxytocin
Beyond the preview
Go deeper on NL-OMON37316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37316.